Skip to main content

Advertisement

SpringerLink
Log in

Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Yoshida M, Osumi T, Imadome KI et al (2018) Successful treatment of systemic EBV positive T-cell lymphoma of childhood using the SMILE regimen. Pediatr Hematol Oncol 35(2):121–124

    Article  PubMed  Google Scholar 

  2. Li J, Ye J, Wang Y, Wang J, Fang Y (2022) Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient. Ann Hematol 101(2):433–435

    Article  PubMed  Google Scholar 

  3. Kim SJ, Park S, Kang ES et al (2015) Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients. Ann Hematol 94(1):71–78

    Article  CAS  PubMed  Google Scholar 

  4. Hung GY, Yu TY, Yen HJ, Yang CF, Lin LY, Horng JL (2019) Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood presentation with hemophagocytosis. J Pediatr Hematol Oncol 41(4):319–320

    Article  PubMed  Google Scholar 

  5. Hue SS, Oon ML, Wang S, Tan SY, Ng SB (2020) Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Pathology 52(1):111–127

    Article  CAS  PubMed  Google Scholar 

  6. Horne A, Janka G, Maarten Egeler R et al (2005) Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 129(5):622–630

    Article  PubMed  Google Scholar 

  7. Wang Y, Huang W, Hu L et al (2015) Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood 126(19):2186–2192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wang J, Wang Y, Wu L, Zhang J, Lai W, Wang Z (2016) PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Hematol Oncol 9(1):84

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wang J, Zhang R, Wu X et al (2021) Ruxolitinib-combined doxorubicin-etoposide-methylprednisolone regimen as a salvage therapy for refractory/relapsed haemophagocytic lymphohistiocytosis: a single-arm, multicentre, phase 2 trial. Br J Haematol 193(4):761–768

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Thank you to the pathologists in our hospital for their expertise and generous sharing of data.

Funding

This research was supported by the Natural Science Foundation of Jiangsu Province (BK20211009) and Scientific Research Projects of Jiangsu Health Commission (ZDB2020018).

Author information

Author notes

  1. Jian Li and Chunyan Cao contributed equally to this work.

Authors and Affiliations

  1. Department of Hematology and Oncology, Children’s Hospital of Nanjing Medical University, Nanjing, China

    Jian Li, Chunyan Cao, Shifeng Lu, LiuCheng Rong, Meiyun Kang & Yongjun Fang

  2. Key Laboratory of Hematology, Nanjing Medical University, Nanjing, 210008, China

    Jian Li, Chunyan Cao, Shifeng Lu, LiuCheng Rong, Meiyun Kang & Yongjun Fang

Authors
  1. Jian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chunyan Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shifeng Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. LiuCheng Rong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meiyun Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yongjun Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Patient management and data curation: Jian Li, Chunyan Cao, Shifeng Lu, Liucheng Rong. Project administration: Yongjun Fang. Writing—original draft: Jian Li and Chunyan Cao. Writing—review and editing: Meiyun Kang and Yongjun Fang. All authors contributed to the article and approved the submitted version.

Corresponding author

Correspondence to Yongjun Fang.

Ethics declarations

Ethics approval and consent to participate

This case was published with parents’ informed consent, and the Nanjing Medical University ethics and plan review committee approved the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Cao, C., Lu, S. et al. Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation. Ann Hematol 102, 2955–2957 (2023). https://doi.org/10.1007/s00277-023-05298-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05298-z

Search

Navigation